Pay in 4 interest-free payments of $5.53 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Trial participants should follow protocol guidance
Answer my questions quickly, delivery is fast and the medication is effective
The phase 2 study showed HbA1c reductions of up to 2.02% at 24 weeks, outcomes that are partially mediated by the same appetite suppression that drives weight loss
Exome sequencing identifies primary carnitine deficiency in a family with cardiomyopathy and sudden death
Retatrutide shows promise as a treatment for obesity, type 2 diabetes, and non-alcoholic fatty liver disease due to its ability to regulate appetite and enhance insulin secretion while suppressing glucagon production
Gautam G, Nakao T
US$ 21.75
US$ 23.92
US$ 24.90
US$ 28.11
US$ 29.23
